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PML, a gene that is involved in the t(15;17) chromosomal 
translocation of acute promyelocytic leukemia (APL), 
encodes a RING–B-box–coiled-coil protein implicated 
in fundamental cellular processes such as genomic sta-
bility, apoptosis, cellular proliferation, and senescence.1,2 
Although cytosolic PML plays an important role in the 
TGF-β pathway and apoptosis,3 PML nuclear body (PML-
NB)–associated PML is responsible for the regulation of 
many different cellular functions.4,5 An increasing body of 
evidence suggests that PML and PML-NBs operate as a hub 
where different pathways converge for positive or negative 
regulation. For instance, PML is involved in p53 activation, 
Rb function and PTEN localization under stress condi-
tions, and also in the repression of the PI3K/Akt pathway 
through inhibition of the nuclear activity of Akt and by 
nuclear relocalization of mTOR.6-11 Importantly, the tumor 
suppressor role of PML is reinforced by the frequent loss of 
this protein and its subnuclear domains in leukemias and 
solid tumors.12 Furthermore, the growth-suppressive func-
tions of PML have been recently implicated in neural and 
hematopoietic stem cell functions.13,14 Interestingly, how-
ever, recent reports strengthen the notion that deregulation 
of PML may also play a crucial role in innate and adaptive 
immunity.15-17 During viral infections type I and II interfer-
ons (IFNs) bind IFN-stimulated response element (ISRE) 
and INF-γ activation site (GAS) elements on the PML and 
SP100 promoters, thereby greatly inducing their transcrip-
tion. The consequence of such infections is a greater num-
ber and size of NBs and a NB-dependent transcriptional 
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Abstract
The promyelocytic leukemia gene (PML) of acute promyelocytic leukemia is an established tumor suppressor gene with critical functions in growth 
suppression, induction of apoptosis, and cellular senescence. Interestingly, although less studied, PML seems to play a key role also in immune response 
to viral infection. Herein, we report that Pml –/– mice spontaneously develop an atypical invasive and lethal granulomatous lesion known as botryomycosis 
(BTM). In Pml –/– mice, BTM is the result of impaired function of macrophages, whereby they fail to become activated and are thus unable to clear 
pathogenic microorganisms. Accordingly, Pml –/– mice are resistant to lipopolysaccharide (LPS)–induced septic shock as a result of an ineffective production 
of cytokines and chemokines, suggesting a role for PML in the innate immune Toll-like receptor (TLR)/NF-κB prosurvival pathway. These results not 
only shed light on a new fundamental function of PML in innate immunity, but they also point to a proto-oncogenic role for PML in certain cellular and 
pathological contexts.
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program to repress viral genes expression.15 If this repre-
sents only a small part of the IFN-mediated viral response 
program, the ability of different classes of viruses to disrupt 
PML-NBs in the first phase of infection provides convinc-
ing evidence that a key function of PML and PML-NBs is 
the mediation of intrinsic antiviral defense.18
Innate immunity is essential for the clearance of bacte-
rial infections. Recognition of fragments of pathogenic 
microbes like LPS, a lipopolysaccharide commonly 
expressed in Gram-negative bacterial membrane, by the 
Toll-like receptors (TLRs) class of molecules is a corner-
stone of innate immunity.19 Ligand-dependent dimerization 
of TLRs is the trigger for potent activation of the NF-κB 
pathway that in turn leads to a rapid induction of prosur-
vival genes (Bcl-2, c-FLIP, IAP, and TRAF molecules) and 
a wide variety of proinflammatory cytokines and chemo-
kines (IL6, IL8, IL10, IL23, IL1α, IL1β, and TNF-α).20
Although innate immunity plays a key role in the defense 
against various invading pathogens, a growing amount of 
evidence describes a tight relationship between inflamma-
tion, tumorigenesis, and tumor progression. Numerous 
recent studies have clearly demonstrated that bacterial- and 
viral-induced inflammatory processes as well as chronic 
inflammation due to tissue injury can mediate tumorigene-
sis.21-25 Infiltrated inflammatory cells, primarily macro-
phages, through the release of cytokines and chemokines 
may be responsible for the activation of TLR/NF-κB path-
way in the cancer cells, thereby promoting cell survival and 
chemoresistance, in addition to activation of neoangiogen-
esis by VEGF production and extracellular matrix break-
down by the release of extracellular matrix proteases.26
Herein, we describe an aberrant immune response of 
Pml –/– mice to spontaneous and experimental bacterial 
infections. We find that Pml –/– macrophages are dysfunc-
tional. Importantly, Pml –/– mice are resistant to the acute 
LPS-mediated lethality observed in wild-type mice, while 
Pml –/– cells display a markedly reduced IL6 response com-
pared to wild-type controls after LPS stimulation. Taken 
together, our data not only demonstrate an important role 
for PML in the innate immunity and acute inflammatory 
response but also suggest a more general function of PML 
in the TLR/NF-κB pathway, shedding light on a possible 
proto-oncogenic role of this gene in the context of chronic 
inflammation-driven tumor development.
Results
Spontaneous botryomycosis and abnormal immunohisto-
pathological features of infected Pml –/– mice. Pml–/– animals 
are extremely prone to develop spontaneous infection when 
housed in a non-pathogen-free area. Although septicemia 
and severely destructive and ulcerating skin infections were 
documented in some cases, the majority of Pml–/– mice suc-
cumb to an unusual tumor-like lesion that resembles what 
has been previously described as “botryomycosis (BTM)” 
(Fig. 1A and 1B). BTM is a chronic granulomatous lesion 
attributed in humans to Actinomycetes or Staphylococcus 
aureus and is thought to be invariably associated with an 
immunocompromised state of the host organism. In fact, it 
should be noted that the lesion is not transmissible from 
animal to animal or from man to animal.27,28 Neither the 
pathogenic mechanism, nor the immunocompromising con-
dition, or the predisposing genetic defect that causes the 
host to respond to an infection by producing chronically 
proliferating and invasive granulomas are currently clear. 
Thirty percent of Pml–/– mice developed spontaneous BTM 
by the first year of age (Fig. 1A and 1B). One hundred per-
cent of these animals showed macroscopic or microscopic 
BTM lesions by 18 months. Although classic BTM presents 
in the head and neck region, several Pml–/– mice were 
affected in the kidney, the preputial glands, or the ovary.
Postmortem characterization of infected Pml–/– animals 
revealed additional striking features, including infections 
other than BTM: 1) proliferation of plasma cells that were 
massively infiltrated into the BTM lesion (Fig. 1C) and 
organs to which the infection apparently had not overtly 
spread (lungs and kidneys were frequently infiltrated; not 
shown). The site of infection was surrounded by large 
hyperplastic lymph nodes characterized by a dramatic pro-
liferation of plasma cells (Fig. 1E). Plasma cell prolifera-
tion was not monoclonal in origin as revealed by 
immunohistochemical staining for κδ immunoglobulin 
light chain of the proliferating plasma cells. Plasma cell 
proliferation was accompanied by an increase of IgG1A in 
the serum of the infected Pml–/– mice as measured by 
ELISA, while uninfected Pml–/– mice showed only a 50% 
reduction of circulating IgE when compared to uninfected 
wild-type controls of the same sex and age. 2) Hyperleuko-
cytosis in the peripheral blood with values >2 × 104 cells/µL; 
3) extramedullary hemopoiesis in the liver and the spleen 
accompanied by massive splenomegaly with marked hyper-
plasia of the white pulp was also invariably observed (Fig. 
1G-I); 4) the presence of abnormal macrophages demon-
strating lipochrome granulation (Fig. 1F). Such abnormal 
macrophages are diagnostic of familial syndromes includ-
ing the various forms of chronic granulomatous disease 
(CGD), characterized by altered macrophage function, and 
are thought to represent engulfed macrophages.29-31 5) The 
lung was frequently damaged irrespective of the primary 
site of infection and the type of infection (Fig. 1J). Areas of 
emphysema and atelectasis were also observed. The alveo-
lar wall was thickened by an infiltrate of mononuclear cells, 
plasma cells, and the deposition of fibrous material. No 
microabscesses were identifiable, and the lung itself was 
never found to be involved as the primary site of infection. 
Interestingly, damaged lungs were also observed in 30% of 
apparently uninfected Pml–/– mice. 6) When the salivary 
gland was the primary site of infection (almost 70% of 
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cases), it showed a marked acinar hyperplasia with clear 
signs of dysplasia in some areas (Fig. 1D).
The almost complete penetrance of this rare and unusual 
infectious lesion in our animal house prompted us to iden-
tify the causative microorganism. In asepsis, we biopsied 2 
cases in which the lesion had a facial presentation and 
looked for the presence of either aerobial or anaerobial bac-
teria or fungi. Staphylococcus aureus was the prominent 
bacterial species isolated, although Escherichia coli, 
Enterococcus, Klebsiella pneumoniae, and Proteus mirabi-
lis were also reported. Neither actinomyces nor fungi were 
isolated from the lesion. It is noteworthy that all the bacte-
rial strains found in the BTM infection are normally found 
in the oral cavity of the mouse. All the bacteria isolated 
were sensitive to all the antibiotics tested including ampi-
cillin. The isolation of Staphylococcus aureus from the 
lesion is in agreement with the Gram-positive staining pat-
tern observed in part of the central region of the abscess.
Hyperproliferative and impaired response to local and sys-
temic experimental infection with Staphylococcus aureus and 
Listeria monocytogenes in Pml–/– mutants. In an attempt to 
reproduce the histopathological findings observed in the 
Pml–/– animals, we tested their responses to experimentally 
induced systemic and local bacterial infections. We first 
determined the minimum lethal intraperitoneal dose 
of Staphylococcus aureus for the 129Sv control mice, 
approximately 5 × 108 cfu, and injected Pml–/– mice and 
Figure 1. Spontaneous botryomycosis in Pml–/– mice. Pathological features of spontaneous botryomicosis affecting Pml–/– mutants. (A) Botryomycosis 
in the salivary gland. The left glandular lobe is almost completely replaced by the lesion; overt hyperplasia of the salivary gland is visible (B, D) and also 
involves the right lobe as indicated by the arrowheads (B). Magnification of the granulomatous area is shown (C): pink cauliflower-like structure consisting 
of bacterial and proteinaceous material is surrounded by granulocytes and macrophages but mainly by plasma cells. Plasma cell infiltration also affected 
organs not directly involved in the infection such as the lung and kidney (not shown). (E) Plasma cell proliferation, as indicated by the arrowheads, 
massively involves the surrounding lymph nodes. (F) Lipochrome granulation of macrophages surrounding the lesion (arrowheads). These cells were also 
infiltrating the lymph nodes and the lungs (not shown). (G) Extramedullary hemopoiesis in the liver. The arrowheads indicate islands of hemopoiesis. 
(H) Extramedullary hemopoiesis in the spleen of infected Pml–/– mice (many megakaryocytes are visible), accompanied by massive splenomegaly 
(I). (J) Interstitial infiltrates of mononuclear cells in the lung. The arrowheads indicate a thickened alveolar wall. Atelectasis of the lung parenchyma is also 
visible. This picture is frequently observed in apparently uninfected mice.
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controls with this dose. The postmortem analysis revealed a 
consistent qualitative difference between the 2 groups. Pml–/– 
mice were characterized by the following: 1) heavily dam-
aged and congested lungs and areas of emphysema and 
atelectasis were frequently observed, and the alveolar wall 
was thickened by an infiltrate of mononuclear cells (Fig. 
2A); 2) a marked proliferation of plasma cells in several 
organs not observed in control animals. In some cases, this 
monomorphic cellular population entirely replaced the red 
pulp of the spleen, causing complete subversion of its nor-
mal structure (Fig. 2B). 3) Disseminated abscesses affect-
ing almost all organs, including the brain, accompanied by 
overt suppurative peritonitis (data not shown); 4) again, 
many pigmented histiocytes were observed in the proximity 
of the abscesses, spleen, and lymph nodes (Fig. 2B). Wild-
type mice, on the contrary, consistently died from renal or 
heart failure due to abscess formation and infraction only 
localized in these organs (data not shown).
The response of Pml–/– mice to localized injection of bac-
teria was tested by inoculating 5 × 107 cfu of Staphylococcus 
aureus into the left lobe of the submandibular salivary gland 
of Pml–/– and control animals. Mice were followed for 10 
days and then sacrificed for postmortem analysis. Already 
after a few days, at clinical examination, the size of injected 
areas was overtly swollen in Pml –/– animals but not in the 
injected controls (Fig. 2C). The postmortem analysis con-
firmed this observation and revealed that the enlargement of 
the injected salivary gland lobe was due to a marked hyper-
plasia of the salivary gland itself and of lymph nodes with 
plasma cell, granulocyte, and mononuclear cell infiltration. 
Due to the presence of abnormal macrophages in the Pml–/– 
mice and in view of the specific up-regulation of PML 
expression by interferons, listeriosis of mice represented a 
preferred model.32 Macrophages, in their resting state, are the 
major habitat for Listeria monocytogenes. Their functional 
activation by various cytokines including interferons, or 
microbial stimuli, converts these cells from being just the 
host of the pathogen into the main effectors of cell resis-
tance.33 Pml–/– and wild-type animals were injected with Lis-
teria monocytogenes (1 × 104 cfu) and sacrificed after 6 days 
or analyzed as soon as spontaneous death occurred. The 
number of bacterial cfu from the spleen and liver homoge-
nate was determined in 3 independent experiments. Four of 
12 Pml–/– mice died spontaneously before day 6, whereas 
only one 129Sv control mouse died at that dose. In 6 of 12 
Pml–/– mice, the colonies obtained were >106, both in the 
liver and in the spleen. In all 3 experiments, the number of 
Listeria monocytogenes colonies obtained from both the 
liver and spleen of the infected Pml–/– animals was 2 loga-
rithms higher than from the controls (Fig. 2D).
Inefficient macrophage “activation” upon Listeria monocyto-
genes infection in Pml–/– mutants. The “activated” macrophage 
is the primary host cell mediating resistance to Listeria 
monocytogenes. Macrophage migration to the site of Liste-
ria replication, activation, phagocytosis, and intracellular 
killing represents 4 different important mechanisms for the 
eradication of Listeria. We first examined whether the 
migration of macrophages into the peritoneal cavity is 
diminished in Pml–/– mice. The cell numbers of peritoneal 
exudate macrophages of untreated wild-type and Pml–/– 
mice 3 to 4 days after peritoneal injection with thioglyco-
late or proteose peptone were comparable, demonstrating 
that the migration of Pml –/– macrophages in the peritoneum 
was not impaired (data not shown). We next examined 
phagocytic activity of macrophages from wild-type and 
Pml–/– mice. Untreated resident macrophages were incu-
bated with zymosan or red cells coated with antibodies in 
order to evaluate the phagocytosis mediated by the Fcγ 
receptors. Macrophages from both Pml–/– and control mice 
phagocytosed zymosan and coated red cells to a similar 
extent, suggesting that the phagocytic activity was not 
impaired (data not shown). Upon exposure to a microorgan-
ism or to various cytokines, untreated resident macrophages 
undergo dramatic functional and morphological changes 
and are then recognized as “activated.” From the morpho-
logical point of view, the plasma membranes of activated 
macrophages become convoluted with ruffling and deep 
invaginations, and the cytoplasm markedly enlarges with 
the prominent appearance of numerous lysosomes.34 Upon 
phagocytosis, lysosomes are almost immediately released 
into the phagosome to form phagolysosome, resulting in the 
killing and digestion of the phagocytosed microorganisms. 
We investigated whether there was any difference between 
Pml–/– and wild-type macrophage activation upon exposure 
to Listeria monocytogenes. Untreated wild-type and Pml –/– 
mice were inoculated intraperitoneally with Listeria. Fif-
teen minutes later, macrophages were harvested and then 
fixed, sectioned, and examined by electron microscopy 
(Fig. 2F-I). The vast majority of macrophages from wild-
type mice showed the expected morphological features: 
convoluted plasma membrane with a nuclear to cytoplas-
mic ratio of <1 and the presence of >10 lysosomes per cell 
(76%) (Table 1). In contrast, Pml–/– macrophages did not 
show such changes. The majority of Pml–/– macrophages 
(75%) were smaller in size (nuclear to cytoplasmic ratio >1) 
with smooth plasma membranes and few or no lysosomes, 
even when phagocytosis was occurring (Fig. 2F-I and 
Table 1). These results indicate that Pml disruption impairs 
the activation capacity of macrophages, resulting in the 
Listeria killing defect observed in vivo in the Pml–/– mice.
While the mechanisms by which active macrophages kill 
intracellular pathogens are diverse and complex, a number of 
studies have demonstrated the importance of nitric oxide 
(NO) as an antimicrobial agent, although in some cases, the 
capacity to kill Listeria can be dramatically reduced even if 
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Figure 2. Aberrant response to infections and impaired macrophage function in Pml–/– mice. (A) Massive abscess and atelectasis due to hyperproliferative 
infiltration of the lung parenchyma in Pml –/– mice infected intraperitoneally with Staphylococcus aureus. Overt peritonitis in 4 of 8 Pml–/– mice was 
also observed. In control mice, abscesses were confined to the kidney and heart (not shown). In all infected Pml –/– mice, plasma cells and lipochrome 
macrophages (arrowheads) infiltrated the spleen and lymph nodes. In 3 cases, these cells completely replaced the red pulp of the spleen as shown (B). 
(C) Hyperplasia of the salivary gland in Pml–/– mice injected locally with Staphylococcus aureus. At postmortem analysis, the injected lobe of the salivary 
gland of all the Pml–/– was overtly swollen. The injected salivary gland of a representative Pml –/– mutant is shown on the right (k/o). Note the hyperplasia 
of the left lobe of the salivary gland itself and the hyperplasia of the surrounding lymph nodes that are fused to the lobe. On the left is an injected salivary 
gland from a control mouse. In this case, the only noticeable alteration is the fibrosis of the injected lobe. (D) Pml–/– mice show impaired response to 
Listeria monocytogenes infections. The number of Listeria colonies from the spleen of the first of 3 consecutive experiments performed with 4 Pml –/– and 
4 wild-type animals is shown. The value obtained from one Pml –/– mutant, which in this experiment spontaneously died at day 5, is indicated by the 
crossed circle. The 2 mean values from the 2 groups are presented by the dashed open circles. The values obtained from the liver in 2 groups were 
comparable to the value obtained for the spleen (not shown). Two additional experiments on 8 Pml –/– and 8 wild-type mice, repeated using the same 
experimental conditions, showed virtually identical results (not shown). The mean values in the 3 experiments showed at least a 100-fold difference 
between the 2 groups. (E) Nitric oxide production by the Pml–/– macrophages. Resident untreated macrophages were collected from both wild-type and 
Pml –/– mice and cultured with or without 1,000 U/mL IFNγ, 100 ng/mL LPS, or both IFNγ and LPS for 48 hours. NO2 concentration in the medium was 
measured with Griess reagent. The experiment shown represents triplicate measurements from the macrophage of 2 Pml–/– and 2 wild-type mice. Three 
independent experiments showed similar results. (F-I) Defective activation in Pml –/– macrophages is shown (F). Wild-type macrophage upon exposure 
to Listeria. The plasma membrane is convoluted with pronounced ruffling. The cytoplasm is large and contains numerous lysosomes as indicated by the 
arrowheads. (G) Pml –/– macrophages upon exposure to Listeria. The plasma membrane is smoother, and the cytoplasm is smaller with few or no lysosomes. 
(H) Phagocytosing wild-type macrophage. Phagolysosomes with phagocytosed Listeria and fusing lysosomes are clearly visible. The arrowheads indicate 
lysosomes ready to fuse to the endosome. The asterisk indicates a phagocytosed bacterium, and the open circle indicates a bacterium already partially 
digested. (I) Phagocytosing Pml –/– macrophage. Phagocytosed bacteria are in vacuoles (see asterisks), but no lysosomes are ready to fuse to them, nor does 
the macrophage seem to be activated. Magnifications are as follows: 4.400x (F, G) and 10.400x (H, I).
PML function in innate immunity and NF-κB pathway / Lunardi et al. 15
NO production is unaltered.35 When untreated resident mac-
rophages were cultured in the presence of IFNγ and LPS for 
24 and 48 hours, the NO production was similar in Pml–/– and 
wild-type macrophage cultures (Fig. 2E). Furthermore, the 
reactive oxygen intermediate production from neutrophils 
evaluated by the NBT test was comparable between wild-
type and Pml–/– mice. These results indicate that normal NO 
production is not sufficient for bactericidal activity and that 
Pml-dependent macrophage activation is essential to kill Lis-
teria monocytogenes.
Impaired LPS response in Pml–/– mice. TLR-4 activation by 
LPS binding results in NF-κB–dependent induction of 
potent effector cytokines such as IL1 and TNF-α. Excessive 
production of cytokines and secondary mediators due to 
high levels of free LPS results in systemic vasodilation 
(hypotension), myocardial pump failure, and disseminated 
intravascular coagulation that in turn cause the multiorgan 
system failure referred to as septic shock syndrome. In 
order to determine whether the BTM phenotype observed in 
Pml–/– mice was attributable to an inefficient macrophage 
activation or to a more general dysfunction of the innate 
immune system and TLR/NF-κB pathway, we challenged 
wild-type and Pml–/– mice with bacterial LPS that have 
been previously reported to induce a fulminant hepatitis in 
mice. Wild-type mice injected intraperitoneally with LPS 
were more sensitive to LPS-induced septic shock and died 
at doses that were not lethal for Pml–/– mice (Table 2). His-
topathological analysis was performed on the liver taken 
from treated animals 48 hours after LPS administration. 
Sections from liver tissue of wild-type mice showed signs 
of fulminant hepatitis. In contrast, the liver from LPS-
treated Pml–/– mice showed no signs of hepatotoxicity. The 
reproducibility of these results in 3 different genetic back-
grounds (C57BL/6, 129Sv, and 129Sv-mixed) provides 
evidence for a model where PML is required for the LPS-
activated TLR-dependent NF-κB pathway.
IL6 production is reduced in Pml–/– mouse embryonic fibro-
blasts. Clinical and epidemiological data suggest a strong 
association between inflammation and different types of can-
cer. In this context, the NF-κB–dependent release of inflam-
matory molecules represents important antiapoptotic and 
growth signals for cancer cells, promoting tumorigenesis and 
tumor progression.36,37 Although widely accepted, detailed 
mechanisms necessary to disentangle the key components of 
this protumorigenic signaling transduction cascade are still 
lacking. Among all the cytokines and chemokines normally 
involved in the inflammatory response, IL6 seems to play a 
key role in malignant transformation. This cytokine has 
been implicated as a growth factor for multiple myeloma, 
epithelial tumors such as breast and prostate cancers, and 
Hodgkin lymphoma.38-40 Recently, Struhl and colleagues 
have described the complex oncogenic mechanism that links 
an inflammatory stimulus through NF-κB/Lin28B/Let-7/
IL6/Stat3 to cellular transformation.23 In particular, the abil-
ity of Let-7 to bind the 3′UTR of IL6 mRNA and to repress 
its expression is completely lost during an inflammatory 
stimulus as a consequence of NF-κB–dependent induction of 
Lin28B. The final result of NF-κB activation is an early and 
extremely high up-regulation of IL6 in comparison to other 
inflammation-related genes, which in turn mediates the acti-
vation of fundamental oncogenic pathways such as JAK/
STAT, VEGF, IL8, IL1A, and IL1B.
In order to determine whether PML could regulate 
the NF-κB/IL6 inflammatory oncogenic network described 
above, we quantitated IL6 production in the supernatant of 
Pml–/– and wild-type C57BL/6–derived mouse embryonic 
fibroblasts (MEFs). In LPS-treated MEFs, IL6 concentra-
tion was found to be on average 2-fold higher in the super-
natant of wild-type with respect to Pml–/– MEF (Fig. 3). 
These data reinforce the hypothesis that PML might be an 
important player in the NF-κB pathway and at the same 
Table 2. Acute Septic Shock Response in Pml–/– and WT Mice 
to LPS Injection
129Sv 129Sv-mixed C57BL/6
WT 0/3 1/4 0/3
Pml–/– 3/3 4/4 3/3
Note: E. coli LPS was injected intraperitoneally in 0.1 mL of sterile 
phosphate-buffered saline. The final result of the experiment (survival) 
was scored after 48 hours.
Table 1. Impaired Pml–/– Macrophage Activation upon Listeria monocytogenes Infection
Lysosomes  
per cell (mean 
value)
Lysosomes in  
nonphagocitosing cell 
(mean value)
% of  
phagocitosing cells
Bacteria per  
cell (mean value)







WT 16.2 17.5 62 2.1 7 76
Pml–/– 7.8 7.4 25 2 25 25
Note: Total number of Mθ scored from 7 fields (3,000x-4,400x) in one electron microscopy section: wild-type (WT) = 21; Pml–/– = 24.
aMacrophages were considered activated when showing extensive ruffling of the plasma membrane and a reduced nucleus/cytoplasm ratio.
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time highlight a possible and unexpected proto-oncogenic 
unrecognized side of this gene in tumors where inflamma-
tion is involved.
Discussion
BTM is rare in humans, although it does have a worldwide 
occurrence, and it is associated with the presence of 
commensal microorganisms such as Actinomycetes and 
Staphylococcus.27,28 Pml–/– mice develop BTM with high 
penetrance and die from BTM in almost 30% of cases by 
their first year of age. By year 2, 100% of Pml–/– mice show 
either overt BTM or BTM-type lesions at postmortem anal-
ysis. In these mice, the spontaneous infections were charac-
terized by the accumulation of lipochrome histiocytes. The 
presence of these cells is associated with a group of inher-
ited diseases, chronic granulomatous disease, characterized 
by impaired macrophage function and susceptibility to 
infections but not by botryomicosis.29 The presence of lipo-
chrome histiocytes in the Pml–/– mutants, the fact that PML 
is specifically up-regulated by interferons and is also up-
regulated in functionally activated macrophages as well as 
in germinal center macrophages,41 prompted us to chal-
lenge the mice with Listeria monocytogenes. This microor-
ganism replicates in the cytoplasm of macrophages and is 
killed by these cells once they became activated by various 
cytokines including interferons.32 Pml–/– mice revealed an 
impaired capacity to clear Listeria infection, once again 
supporting the notion of altered macrophage function in 
these mice. The “activated” macrophage is the primary host 
cell mediating immunity to Listeria monocytogenes, while 
migration of macrophages to the site of Listeria replication, 
phagocytosis, and intracellular killing represent important 
mechanisms for the eradication of Listeria. Pml–/– macro-
phages can migrate into the peritoneal cavity in response to 
various stimuli and can phagocytose but are not properly 
activated upon exposure to Listeria. Lack of “activation” 
together with the concomitant altered digestion of the 
phagocytosed material due to the reduced number of lyso-
somes, as also shown by the accumulation of lipids in mac-
rophages, explains the immune response defect underlying 
the spontaneous occurrence of the botryomycotic granu-
loma. Pml–/– macrophages are capable of producing NO 
upon exposure to LPS and interferons, indicating that PML 
is not implicated in controlling the transcriptional activa-
tion of the iNOS genes induced by LPS and IFNs.
The hyperproliferative response observed in infected 
Pml–/– mice can be experimentally reproduced when the 
mice are challenged, either locally or systemically, with 
infectious agents. PML’s dual role in controlling cell prolif-
eration as well as the functional activation of macrophages 
would explain why Pml mutants preferentially develop 
such an unusual lesion as BTM through a combined mecha-
nism of hyperproliferation, impaired clearance, and bacte-
rial trapping, at the same time disclosing the pathogenetic 
and predisposing factors that result in this rare condition.
In this regard, it is interesting to note that some patho-
gens are able to escape the acute immune response and 
establish a persistent infection responsible for a low-grade 
chronic inflammation. This asymptomatic pathological sta-
tus has been recently linked to different phases of tumor 
development in malignancies such as cervical cancer, hepa-
tocellular carcinoma, lymphoproliferative disorders, and 
gastric tumors, respectively, due to chronic infection by 
human papilloma virus (HPV), hepatitis B and C viruses 
(HBV, HCV), Epstein-Barr virus (EBV), and Helicobacter 
pylori.21 In the majority of these cases, the crucial tumori-
genic factor is the chronic inflammation more than the acti-
vation of a specific pathogen’s oncogenes. In particular, 
mature T cells and tumor-associated macrophages (TAMs) 
are the 2 classes of immune cells most frequently found 
associated with solid tumors. Both cell types are involved 
in tumor initiation and progression through cytokines (IL1, 
IL6, IL17, IL23, and TNF-α) and proangiogenic (VEGF) 
and prometastatic (EGF, TGF-β) factors release.
The NF-κB signaling pathway has emerged as the cen-
tral node that links, at the molecular level, inflammation 
and tumorigenesis.23,42 The IKK/NF-κB system plays mul-
tiple roles in this particular game: 1) it can promote cellular 
transformation; 2) it is able to trigger survival pathways in 
tumor cells, counteracting proapoptotic stimuli; 3) it drives 
Figure 3. Impaired IL6 production in Pml–/– MEFs. Secreted IL6 was 
measured in the medium by ELISA and is expressed relative to total 
protein content of incubated MEFs. Five independent experiments 
showed a statistically significant 2-fold decrease of IL6 protein secretion 
from Pml–/– versus wild-type MEFs after LPS treatment. The mean values 
are presented by the solid lines ± standard deviation.
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the synthesis and release of cytokines and growth factors in 
the immune cells that are necessary for tumor development 
and invasiveness.
By using a mouse model of colitis-associated colorectal 
cancer in which the gene encoding IKKβ, essential for the 
activation of the NF-κB pathway, was knocked out in either 
myeloid or intestinal epithelial cells, Greten and colleagues 
set out the conditions to discern the different cell-dependent 
contributions of the NF-κB pathway to the inflammation-
related tumor development. IKKβ knockout in the intestinal 
epithelial cells determined an 80% decrease in tumor inci-
dence versus only 50% when the NF-κB pathway was 
affected in the macrophages.24 Although the exact mecha-
nism of the noncell-autonomous role in macrophages 
remained unclear, a cell-autonomous NF-κB–dependent 
suppression of the mitochondrial apoptosis through the 
induction of its target gene Bcl-X
L
 has been proposed. Sup-
port for NF-κB’s antiapoptotic role in inflammation-driven 
tumorigenesis came from studies on Mdr2 knockout mice, 
a faithful model of hepatitis and hepatocellular carcinoma. 
Through the genetic alteration of IκBα, an important inhibi-
tor of the NF-κB pathway, Pikarsky and colleagues charac-
terized a fundamental antiapoptotic function of NF-κB in 
the transformed hepatocytes necessary for the progression 
to the hepatocellular carcinoma.25
Intriguingly, all the phenotypes described in Pml –/– mice, 
including defects in macrophage activation, deregulation of 
cytokine/chemokine expression, altered response to LPS, 
and cellular hyperproliferation, are reminiscent of and 
could be potentially attributed to a dysfunction of the 
NF-κB pathway. In this regard, the detailed analysis of 
the role of PML in the modulation of the NF-κB pathway 
represents an exciting challenge for future studies, not 
only to further define the role of PML in the innate immune 
response but also to ascertain a possible unanticipated 
proto-oncogenic function for PML in chronic inflamma-
tion-driven tumor development.
Materials and Methods
Pml –/– mice. Pml –/– mice were previously generated.43 All 
mouse work was performed in accordance with our IACUC-
approved protocols.
Autopsy, histopathology, and immunohistochemistry of mice. 
Animals were autopsied as needed, and all tissues were 
examined regardless of their pathological status. Tissues 
were formalin fixed, dehydrated, and embedded in paraffin 
according to standard protocols. Sections (4-5 µm) were 
stained with hematoxylin and eosin and examined micro-
scopically. Standard Gram and GMS staining procedures 
were carried out in order to characterize the microorgan-
isms in the botryomycotic lesion.
Staphylococcus aureus and Listeria monocytogenes infections. 
For local and systemic infection with Staphylococcus sub-
species, aureus (ATCC 25923) was utilized. 5 × 108 cfu of 
bacteria resuspended in 300 µL of PBS were injected intra-
peritoneally into 8 controls and 8 Pml –/– 8- to 12-week-old 
mice. Histopathological analysis was carried out when spon-
taneous death occurred. 5 × 107 cfu of Staphylococcus aureus 
were injected into the left lobe of the submandibular salivary 
gland of six 8- to 12-week-old Pml –/– and 6 control mice. 
Animals were sacrificed after 10 days, and postmortem his-
topathological analysis was performed. For the Listeria 
infections, mice were injected intravenously with 104 cfu of 
Listeria monocytogenes (ATCC 7302). The number of viable 
bacteria recovered from the spleen and the liver was deter-
mined 6 days after the injection or immediately after sponta-
neous death occurred by plating serial 10-fold dilutions of 
organ homogenates in PBS on trypticase soy agar plate. 
Three independent experiments were carried out using 4 
Pml –/– and 4 wild-type mice for each experiment.
Preparation of untreated resident macrophages or thioglycol-
late or proteose peptone–elicited peritoneal macrophages. 
Mice were sacrificed 3 days after intraperitoneal injection 
of 2 mL of 3% Brewer thioglycollate medium or 4 days 
after intraperitoneal injection of 2 mL of 10% proteose pep-
tone. Resident macrophages were also harvested from 
untreated mice. Peritoneally exudated cells were harvested 
by washing the peritoneal cavity with 5 mL of RPMI 
medium. The cells were cultured for 2 hours in LPS-free 
RPMI 1640, 10% FCS, 2 mM L-glutamine, penicillin G 
(100 U/mL), and streptomycin (100 µg/mL). Nonadherent 
cells were removed, and the remaining macrophage mono-
layer was used for further experiments.
Transmission electron microscopy of peritoneal macrophages 
infected with Listeria monocytogenes. Wild-type and Pml –/– 
mice were injected intraperitoneally with 107 cfu of Listeria 
monocytogenes resuspended in RPMI 10% FCS. Fifteen 
minutes later, peritoneal cells were harvested and stained 
with Wright staining for morphological analysis or fixed 
with 3% formaldehyde and 3% glutaraldehyde in 0.1 M 
Miloning’s phosphate buffer. The cells were then sectioned 
and examined with a Philips model 410EM transmission 
electron microscope (Amsterdam, the Netherlands).
NBT reaction. There was 50 µL of peripheral blood from 
4 Pml –/– and 4 wild-type control mice added to 50 µL of 
NBT solution (1 mg of nitroblue tetrazolium per mL of 
PBS) in a siliconized vial, with or without bacterial extract 
(Sigma-Aldrich, St. Louis, MO). After 10 minutes at 37°C, 
cells were transferred onto a clean glass slide. The positive 
cells were scored by microscopy. At least 400 cells per 
mouse were scored.
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Nitric oxide production by macrophages. Resident untreated 
macrophages were collected from both wild-type and 
Pml –/– mice and plated on a 96-well plate at a density of 1 
× 105 cells/well. Adherent cells were cultured with or with-
out 100 U/mL IFNγ, 100 ng/mL LPS, or both IFNγ and LPS 
for 24 or 48 hours. NO concentration in the medium was 
measured with Griess reagent.44
LPS treatment. LPS (L-3129) was purchased from Sigma-
Aldrich. Mice were injected intraperitoneally with, respec-
tively, 5 mg (129Sv and 129Sv-mixed) and 1 mg (C57BL/6) 
of reagents dissolved in 0.1 mL of phosphate-buffered 
saline.
IL6 quantification by ELISA. An equal amount of primary 
MEFs derived from wild-type (n = 3) and Pml –/– (n = 3) 
C57BL/6 mice was seeded 12 hours before treatment in 
DMEM containing 10% FBS and 2 mM glutamine. Super-
natants from wild-type and Pml –/– MEFs untreated or chal-
lenged with 100 ng/mL LPS for 24 hours were analyzed for 
IL6 by using a commercially available murine IL6 ELISA 
kit (Thermo Scientific EM2IL6, Waltham, MA) according 
to the manufacturer’s recommendations. IL6 values were 
normalized to total amount of proteins isolated from wild-
type and Pml –/– MEFs, respectively.
Statistical analysis. Results are expressed as mean ± stan-
dard deviation. Comparisons between groups were assessed 
using Student t test analysis (Excel, Microsoft, Redmond, 
WA). P ≤ 0.05 was considered significant.
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